A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
Clinical trial NCT02677116 · COMPLETED
Trial details
- NCT number
- NCT02677116
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-29
- Primary completion
- 2018-10-10
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.